Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

April 18, 2024

Study Completion Date

May 7, 2024

Conditions
OverweightObesity
Interventions
DRUG

Semaglutide

Semaglutide tablets orally once daily for 64 weeks.

DRUG

Placebo semaglutide

Semaglutide placebo-matching tablets orally once daily for 64 weeks.

Trial Locations (22)

22206

Washington Cntr Weight Mgmt, Arlington

22601

Selma Medical Associates, Winchester

23758

RED-Institut für medizinische Forschung und Fortbildung GmbH, Oldenburg in Holstein

28401

Accellacare, Wilmington

35294

Univsty Of AL At Birmingham, Birmingham

45136

InnoDiab Forschung GmbH, Essen

48153

MedicalCenter am Clemenshospital - Schwerpunktpraxis für Diabetologie und Ernährungsmedizin, Münster

49808

Diabetologische Gemeinschaftspraxis Dr. Staudenmeyer und Dr. Schiwietz, Lingen

66780

Praxis Dr. med. Wenzl-Bauer, Rehlingen-Siersburg

70378

MZM Praxis Drs. Erlinger, Stuttgart

78048

Jacob, Villingen-Schwenningen, Villingen-Schwenningen

88239

Zentrum für klinische Studien Allgäu Oberschwaben, Wangen

92627

FDRC, Costa Mesa

75390-9302

UT Southwestern Med Cntr, Dallas

E1G 1A7

G.A. Research Associates Ltd., Moncton

L8L 5G8

Wharton Med Clin Trials, Hamilton

59-220

"Beata Mikłaszewicz&Dariusz Dąbrowski CARDIAMED s.j.", Legnica

20-412

ETG Lublin, Lublin

08-110

ETG Siedlce, Siedlce

02-677

ETG Warszawa Sp. z o.o., Warsaw

15-281

Gabinet Leczenia Otylosci i Chorob Dietozaleznych, Bialystok

60-589

Centrum Zdrowia Metabolicznego, Poznan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05564117 - Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range | Biotech Hunter | Biotech Hunter